Lovesac, Avidity Biosciences, Veritone, and Other Major Stocks Decline in Thursday's Pre-Market Trading
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 11 2025
0mins
Source: Benzinga
U.S. Stock Futures: U.S. stock futures are up, with Dow futures increasing by approximately 0.2% on Thursday morning.
Lovesac Co Performance: Lovesac Co's shares fell 13% in pre-market trading after reporting a second-quarter loss of 45 cents per share, which was better than expected, but the company lowered its FY2026 EPS guidance significantly.
Other Stocks Declining: Several other stocks also saw significant declines in pre-market trading, including Avidity Biosciences (down 20.1%) and Veritone, Inc. (down 18.7%), following announcements of stock offerings.
Market Overview: The overall market sentiment appears cautious, with multiple companies experiencing sharp declines in their stock prices amid earnings reports and new offerings.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VERI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VERI
Wall Street analysts forecast VERI stock price to rise
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 1.255
Low
6.00
Averages
8.33
High
10.00
Current: 1.255
Low
6.00
Averages
8.33
High
10.00
About VERI
Veritone, Inc. builds human-centered enterprise artificial intelligence (AI) solutions. Its AI operating system, aiWARE, uses machine learning algorithms, or AI models, together with a suite of applications, to reveal valuable insights from vast amounts of structured and unstructured data. Highly modular and customizable, aiWARE enables expansive scale with the flexibility to deploy in the cloud, at the edge or in hybrid environments. Its aiWARE platform offers capabilities that are designed to mimic human cognitive functions such as perception, prediction and problem solving, enabling users to transform unstructured data into structured data, and analyze and optimize data to drive business processes and insights. Its aiWARE platform encompasses industry applications, automate studio and developer APIs, intelligent data lake, applications and cognitive analytics, and generative AI. It serves customers in the media, entertainment, public sector and talent acquisition industries.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Class Action Filed Against Veritone, Inc. by Shareholders
- Lawsuit Background: Robbins LLP reminds shareholders that a class action has been filed on behalf of investors who purchased Veritone (NASDAQ: VERI) securities between October 14, 2025, and April 14, 2026, alleging the company failed to disclose deficiencies in its internal financial controls.
- Financial Misconduct: The lawsuit claims that during this period, Veritone inaccurately recorded and/or misclassified certain revenues and costs, leading to an overstatement of revenue, assets, and other comprehensive income, which severely impacted investor confidence.
- Internal Control Deficiencies: Shareholders assert that the company maintained deficient internal controls over accounting and financial reporting, ultimately forcing the company to restate certain financial statements, exacerbating investor losses.
- Next Steps: Shareholders wishing to serve as lead plaintiffs in the class action must submit their papers by July 20, 2026, while those who choose not to participate can remain absent class members and retain their rights to recovery.
See More
Hagens Berman Investigates Veritone for Financial Misstatements
- Allegations of Fraud: Hagens Berman is investigating Veritone and its executives for significant misstatements in financial reports from October 14, 2025, to April 14, 2026, which could lead to investor losses and damage the company's reputation and stock price.
- Stock Price Volatility: On March 26, 2026, Veritone announced it was “finalizing its accounting determination of certain revenue transactions,” resulting in a more than 29% drop in share price the following day, indicating severe market concerns over the company's financial transparency.
- Deficient Internal Controls: The investigation reveals that Veritone maintained deficient internal controls over accounting and financial reporting, failing to accurately record and classify revenues and costs, which may have misled investors about the company's financial health and exacerbated market distrust.
- Investor Rights Protection: Investors who suffered losses during the class period may be eligible to serve as lead plaintiffs in the ongoing litigation, with a court-imposed deadline of July 20, 2026, highlighting the importance of protecting investor rights.
See More
Veritone Faces Class Action Lawsuit
- Lawsuit Background: Bragar Eagel & Squire, P.C. has announced a class action lawsuit against Veritone on behalf of all investors who purchased its securities between October 14, 2025, and April 14, 2026, highlighting serious concerns regarding the company's financial transparency.
- Allegation Details: The lawsuit alleges that Veritone made false statements and failed to disclose critical information in its financial reporting, resulting in overstated revenue and assets, which may necessitate a restatement of financial statements, thereby impacting investor confidence.
- Investor Losses: Investors suffered damages when the true financial condition of the company was revealed, reflecting doubts about corporate governance and internal controls, which could lead to a decline in stock price.
- Next Steps: Investors must apply by July 20, 2026, to be appointed as lead plaintiffs in the lawsuit, indicating a proactive stance on potential legal actions and compensation, emphasizing the importance of investor engagement in legal proceedings.
See More
Hagens Berman Investigates Veritone for Financial Misstatements
- Allegations of Fraud: Hagens Berman is investigating Veritone and its executives for admitting to significant errors in financial statements, potentially violating securities laws and causing investor losses.
- Significant Stock Decline: Multiple disclosures in early 2026 led to a sharp decline in Veritone's stock price, reflecting market disappointment with the company's financial performance and impacting investor confidence.
- Urgent Litigation Timeline: Investors who purchased Veritone securities between October 14, 2025, and April 14, 2026, and suffered losses must apply to be lead plaintiffs by July 20, 2026, to seize legal opportunities.
- Whistleblower Reward Program: Hagens Berman encourages individuals with non-public information to assist in the investigation, with rewards of up to 30% of any successful SEC recovery, further promoting corporate accountability.
See More
Reminder for Veritone Securities Class Action
- Class Action Notice: Rosen Law Firm reminds investors who purchased Veritone securities between October 14, 2025, and April 14, 2026, to apply as lead plaintiffs by July 20, 2026, to potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Veritone made false and misleading statements during the class period, resulting in inflated revenue and assets, which led to investor losses and highlighted deficiencies in the company's internal controls over financial reporting.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest settlement against a Chinese company, being ranked No. 1 by ISS Securities Class Action Services in 2017, showcasing its strong track record and expertise in this field.
- Investor Action Advice: Investors can visit the Rosen Law Firm website or call the toll-free number for more information, emphasizing the importance of selecting qualified legal counsel to ensure effective representation in the lawsuit and avoid inexperienced intermediaries.
See More
Veritone Faces Class Action Lawsuit Impacting Stock Price
- Class Action Initiated: Pomerantz LLP has announced a class action lawsuit against Veritone, alleging securities fraud by the company and certain executives, with investors needing to apply by July 20, 2026, to become lead plaintiffs, indicating significant legal risks that could undermine market confidence in the company.
- Delayed Financial Reporting: On April 1, 2026, Veritone filed an NT 10-K with the SEC, revealing its inability to timely submit its annual report for fiscal year 2025 due to delays in finalizing accounting determinations, which may lead to substantial adjustments in financial data, highlighting a lack of financial transparency.
- Stock Price Volatility: Following the exposure of financial issues, Veritone's stock price plummeted by 29.5% on March 27 and 9.14% on April 1, 2026, reflecting strong market concerns regarding the company's financial health, which could adversely affect investor confidence.
- Financial Data Errors: In a Form 8-K filed on April 14, 2026, the company acknowledged significant errors in its previously issued financial statements, resulting in a substantial overstatement of revenue and understatement of net loss, further intensifying market skepticism about its financial reporting and potentially impacting future financing capabilities.
See More
Class Action Filed Against Veritone, Inc. by Shareholders
- Lawsuit Background: Robbins LLP reminds shareholders that a class action has been filed on behalf of investors who purchased Veritone (NASDAQ: VERI) securities between October 14, 2025, and April 14, 2026, alleging the company failed to disclose deficiencies in its internal financial controls.
- Financial Misconduct: The lawsuit claims that during this period, Veritone inaccurately recorded and/or misclassified certain revenues and costs, leading to an overstatement of revenue, assets, and other comprehensive income, which severely impacted investor confidence.
- Internal Control Deficiencies: Shareholders assert that the company maintained deficient internal controls over accounting and financial reporting, ultimately forcing the company to restate certain financial statements, exacerbating investor losses.
- Next Steps: Shareholders wishing to serve as lead plaintiffs in the class action must submit their papers by July 20, 2026, while those who choose not to participate can remain absent class members and retain their rights to recovery.
See More
Hagens Berman Investigates Veritone for Financial Misstatements
- Allegations of Fraud: Hagens Berman is investigating Veritone and its executives for significant misstatements in financial reports from October 14, 2025, to April 14, 2026, which could lead to investor losses and damage the company's reputation and stock price.
- Stock Price Volatility: On March 26, 2026, Veritone announced it was “finalizing its accounting determination of certain revenue transactions,” resulting in a more than 29% drop in share price the following day, indicating severe market concerns over the company's financial transparency.
- Deficient Internal Controls: The investigation reveals that Veritone maintained deficient internal controls over accounting and financial reporting, failing to accurately record and classify revenues and costs, which may have misled investors about the company's financial health and exacerbated market distrust.
- Investor Rights Protection: Investors who suffered losses during the class period may be eligible to serve as lead plaintiffs in the ongoing litigation, with a court-imposed deadline of July 20, 2026, highlighting the importance of protecting investor rights.
See More
Veritone Faces Class Action Lawsuit
- Lawsuit Background: Bragar Eagel & Squire, P.C. has announced a class action lawsuit against Veritone on behalf of all investors who purchased its securities between October 14, 2025, and April 14, 2026, highlighting serious concerns regarding the company's financial transparency.
- Allegation Details: The lawsuit alleges that Veritone made false statements and failed to disclose critical information in its financial reporting, resulting in overstated revenue and assets, which may necessitate a restatement of financial statements, thereby impacting investor confidence.
- Investor Losses: Investors suffered damages when the true financial condition of the company was revealed, reflecting doubts about corporate governance and internal controls, which could lead to a decline in stock price.
- Next Steps: Investors must apply by July 20, 2026, to be appointed as lead plaintiffs in the lawsuit, indicating a proactive stance on potential legal actions and compensation, emphasizing the importance of investor engagement in legal proceedings.
See More
Hagens Berman Investigates Veritone for Financial Misstatements
- Allegations of Fraud: Hagens Berman is investigating Veritone and its executives for admitting to significant errors in financial statements, potentially violating securities laws and causing investor losses.
- Significant Stock Decline: Multiple disclosures in early 2026 led to a sharp decline in Veritone's stock price, reflecting market disappointment with the company's financial performance and impacting investor confidence.
- Urgent Litigation Timeline: Investors who purchased Veritone securities between October 14, 2025, and April 14, 2026, and suffered losses must apply to be lead plaintiffs by July 20, 2026, to seize legal opportunities.
- Whistleblower Reward Program: Hagens Berman encourages individuals with non-public information to assist in the investigation, with rewards of up to 30% of any successful SEC recovery, further promoting corporate accountability.
See More
Reminder for Veritone Securities Class Action
- Class Action Notice: Rosen Law Firm reminds investors who purchased Veritone securities between October 14, 2025, and April 14, 2026, to apply as lead plaintiffs by July 20, 2026, to potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Veritone made false and misleading statements during the class period, resulting in inflated revenue and assets, which led to investor losses and highlighted deficiencies in the company's internal controls over financial reporting.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest settlement against a Chinese company, being ranked No. 1 by ISS Securities Class Action Services in 2017, showcasing its strong track record and expertise in this field.
- Investor Action Advice: Investors can visit the Rosen Law Firm website or call the toll-free number for more information, emphasizing the importance of selecting qualified legal counsel to ensure effective representation in the lawsuit and avoid inexperienced intermediaries.
See More
Veritone Faces Class Action Lawsuit Impacting Stock Price
- Class Action Initiated: Pomerantz LLP has announced a class action lawsuit against Veritone, alleging securities fraud by the company and certain executives, with investors needing to apply by July 20, 2026, to become lead plaintiffs, indicating significant legal risks that could undermine market confidence in the company.
- Delayed Financial Reporting: On April 1, 2026, Veritone filed an NT 10-K with the SEC, revealing its inability to timely submit its annual report for fiscal year 2025 due to delays in finalizing accounting determinations, which may lead to substantial adjustments in financial data, highlighting a lack of financial transparency.
- Stock Price Volatility: Following the exposure of financial issues, Veritone's stock price plummeted by 29.5% on March 27 and 9.14% on April 1, 2026, reflecting strong market concerns regarding the company's financial health, which could adversely affect investor confidence.
- Financial Data Errors: In a Form 8-K filed on April 14, 2026, the company acknowledged significant errors in its previously issued financial statements, resulting in a substantial overstatement of revenue and understatement of net loss, further intensifying market skepticism about its financial reporting and potentially impacting future financing capabilities.
See More
